APA (7th ed.) Citation

Fabisiak, A., Włodarczyk, M., Fabisiak, N., Storr, M., & Fichna, J. (2019). Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal & Liver Diseases, 28(4), 473. https://doi.org/10.15403/jgld-265

Chicago Style (17th ed.) Citation

Fabisiak, Adam, Marcin Włodarczyk, Natalia Fabisiak, Martin Storr, and Jakub Fichna. "Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists Suggest Their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis." Journal of Gastrointestinal & Liver Diseases 28, no. 4 (2019): 473. https://doi.org/10.15403/jgld-265.

MLA (9th ed.) Citation

Fabisiak, Adam, et al. "Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists Suggest Their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis." Journal of Gastrointestinal & Liver Diseases, vol. 28, no. 4, 2019, p. 473, https://doi.org/10.15403/jgld-265.